Global Crohns Disease Treatment Market Size 2024, Forecast To 2033
6 Mar, 2024
The crohn's disease treatment market has exhibited strong growth, expanding from $11.82 billion in 2023 to $12.6 billion in 2024, with a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period is attributed to factors such as increased disease prevalence, advancements in diagnostic techniques, the adoption of biological therapies, growing patient awareness and education, and significant clinical research and development efforts. Moving forward, the crohn's disease treatment market is poised for robust growth, reaching $16.32 billion in 2028 at a CAGR of 6.7%. Factors contributing to this anticipated growth in the forecast period include personalized medicine approaches, the expansion of the biologics market, evolving treatment guidelines, increased healthcare spending, and collaborative research efforts. Noteworthy trends for 2028 involve the incorporation of telemedicine for patient management, ongoing research on immune modulation strategies, the establishment of patient-centric care models, and the integration of digital health solutions for enhanced healthcare delivery.
Global Crohns Disease Treatment Market Key Driver
The Crohn's disease treatment market is poised for significant growth due to the increasing prevalence of inflammatory bowel disorders worldwide. Inflammatory bowel disorders encompass a range of chronic conditions characterized by inflammation in the gastrointestinal tract, affecting millions globally and impairing their quality of life. Crohn's disease treatment aims to alleviate symptoms, reduce inflammation, and maintain remission in affected individuals. As highlighted in a survey by the American Gastroenterological Association in April 2020, more than 40% of adult respondents across 33 countries reported functional gastrointestinal disorders, underscoring the widespread impact of inflammatory bowel disorders. This rising prevalence drives the demand for effective Crohn's disease treatment options, thereby fueling the growth of the market.
Get A Free Sample Of The Global Crohns Disease Treatment Market ReportGlobal Crohns Disease Treatment Market Segments
The crohn's disease treatment market covered in this report is segmented –
1) By Drug Type: Antibiotics, Amino Salicylates, Corticosteroids, Immunomodulators, Other Drug Types
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
3) By Application: Neuropathic Pain, Fibromyalgia, Chronic Back Pain, Arthritic Pain, Migraine Post-Operative Pain, Cancer Pain, Other Applications
By Geography:The regions covered in the crohn's disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the global Crohn's disease treatment market in 2023, and is expected to be the fastest-growing region in the forecast period. The regions covered in the crohn's disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Crohns Disease Treatment Industry Players
AbbVie Inc., AstraZeneca plc, Boehringer Ingelheim GmbH, Celgene Corporation, Eli Lilly and Company, Janssen Pharmaceuticals, Pfizer Inc., Takeda Pharmaceutical Company Limited, Biogen Inc., Bristol-Myers Squibb Company, Galapagos NV, Gilead Sciences Inc., Novartis AG, Sanofi S.A., Union Chimique Belge, Astellas Pharma Inc., F. Hoffmann-La Roche Ltd., Vertex Pharmaceuticals Incorporated, Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Regeneron Pharmaceuticals Inc., Mylan N.V., Glenmark Pharmaceuticals, Tillotts Pharma AG, Dr. Falk Pharma GmbH, Shire Pharmaceuticals, Salix Pharmaceuticals, Prometheus Laboratories Inc., Arena Pharmaceuticals Inc.
Get The Full Global Crohns Disease Treatment Market Report
Crohns Disease Treatment Market Overview
Crohn's disease treatment refers to medical intervention and therapies used to manage Crohn's disease, a chronic pathological condition of the gastrointestinal tract. The treatment aims are to reduce inflammation in the intestines, prevent flare-ups of symptoms, and maintain recovery.
Crohns Disease Treatment Global Market Report 2023 provides data on the global crohns disease treatment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The crohns disease treatment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.